CompletedNot Applicable

Identification of Biomarkers in Spinocerebellar Ataxia 3

United States22 participantsStarted 2019-02-21

Plain-language summary

The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: •Confirmed Genetic Testing of SCA3 or Healthy Volunteers Exclusion Criteria: * People with: * unstable thyroid * unstable intestinal/stomach issues * unstable heart issues * unstable liver issues * unstable kidney issues * unstable lung issues * unstable hormone issues * unstable mental disorders at screening * a tumor or evidence of having a tumor * a chronic infection or any severe acute infection within 3 months prior to screening * People who: * Take anti-coagulants and NSAIDs * Have started any investigational medications in the last month * Women who are pregnant or breast feeding

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Ataxin 3 Levels in Cerebrospinal Fluid Specimens

Timeframe: 4 Hours

Change in Ataxin 3 Levels in Blood Plasma Specimens

Timeframe: 4 Hours

Trial details

NCT IDNCT03885167

SponsorUniversity of Michigan

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-04

View on ClinicalTrials.gov More Spinocerebellar Ataxia Type 3 trials